Embolization and Coiling Devices – Medical Devices Pipeline Assessment, 2017

Embolization and Coiling Devices include devices used to treat aneurysms and other blood vessel malformations called fistulas that occur in the brain. This segment includes embolization coils and liquid embolic systems. GlobalData's Medical Devices sector report, “Embolization and Coiling Devices – Medical Devices Pipeline Assessment, 2017" provides comprehensive information about the Embolization and Coiling Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Scope

The Embolization and Coiling Devices Pipeline Assessment report provides key information and data related to:

• Extensive coverage of the Embolization and Coiling Devices under development.

• Review details of major pipeline products which include product description, licensing and collaboration details and other developmental activities including pipeline territories, regulatory paths and estimated approval dates.

• Reviews of major players involved in the pipeline product development.

• Provides key clinical trial data related to ongoing clinical trials such as trial phase, trial status, trial start and end dates, and, the number of trials of the major Embolization and Coiling Devices pipeline products.

• Review of recent developments in the segment / industry.

Reasons to buy

The Embolization and Coiling Devices Pipeline Assessment report enables you to:

• Access significant competitor information, analysis, and insights to improve your R&D strategies.

• Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

• Identify and understand important and diverse types of Embolization and Coiling Devices under development.

• Formulate market-entry and market expansion strategies.

• Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.

Companies mentioned

Aneuclose LLC

Avantec Vascular Corporation

BioCure, Inc.

Collagen Matrix Inc

DePuy Synthes Inc

Insera Therapeutics, LLC

Medtronic plc

MicroPort Scientific Corp

MicroVention, Inc.

MiVi Neuroscience, LLC

Neuravi Ltd

Shape Memory Therapeutics, Inc.

Taewoong Medical Co Ltd

Terumo Corp

University of California Los Angeles

University of Minnesota

University of Wisconsin Madison

Valor Medical Inc

Vascular Solutions Inc

Table of Contents

1 Table of Contents 2

1.1 List of Tables 5

1.2 List of Figures 6

2 Introduction 7

2.1 Embolization and Coiling Devices Overview 7

3 Products under Development 8

3.1 Embolization and Coiling Devices – Pipeline Products by Stage of Development 8

3.2 Embolization and Coiling Devices – Pipeline Products by Segment 9

3.3 Embolization and Coiling Devices – Pipeline Products by Territory 10

3.4 Embolization and Coiling Devices – Pipeline Products by Regulatory Path 11

3.5 Embolization and Coiling Devices – Pipeline Products by Estimated Approval Date 12

3.6 Embolization and Coiling Devices – Ongoing Clinical Trials 13

4 Embolization and Coiling Devices – Pipeline Products under Development by Companies 14

4.1 Embolization and Coiling Devices Companies – Pipeline Products by Stage of Development 14

4.2 Embolization and Coiling Devices – Pipeline Products by Stage of Development 15

5 Embolization and Coiling Devices Companies and Product Overview 16

5.1 Aneuclose LLC Company Overview 16

5.1.1 Aneuclose LLC Pipeline Products & Ongoing Clinical Trials Overview 16

5.2 Avantec Vascular Corporation Company Overview 17

5.2.1 Avantec Vascular Corporation Pipeline Products & Ongoing Clinical Trials Overview 17

5.3 BioCure, Inc. Company Overview 18

5.3.1 BioCure, Inc. Pipeline Products & Ongoing Clinical Trials Overview 18

5.4 Collagen Matrix Inc Company Overview 19

5.4.1 Collagen Matrix Inc Pipeline Products & Ongoing Clinical Trials Overview 19

5.5 DePuy Synthes Inc Company Overview 20

5.5.1 DePuy Synthes Inc Pipeline Products & Ongoing Clinical Trials Overview 20

5.6 Insera Therapeutics, LLC Company Overview 21

5.6.1 Insera Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview 21

5.7 Medtronic plc Company Overview 22

5.7.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 22

5.8 MicroPort Scientific Corp Company Overview 26

5.8.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 26

5.9 MicroVention, Inc. Company Overview 29

5.9.1 MicroVention, Inc. Pipeline Products & Ongoing Clinical Trials Overview 29

5.10 MiVi Neuroscience, LLC Company Overview 35

5.10.1 MiVi Neuroscience, LLC Pipeline Products & Ongoing Clinical Trials Overview 35

5.11 Neuravi Ltd Company Overview 36

5.11.1 Neuravi Ltd Pipeline Products & Ongoing Clinical Trials Overview 36

5.12 Shape Memory Therapeutics, Inc. Company Overview 40

5.12.1 Shape Memory Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 40

5.13 Taewoong Medical Co Ltd Company Overview 41

5.13.1 Taewoong Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 41

5.14 Terumo Corp Company Overview 43

5.14.1 Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview 43

5.15 University of California Los Angeles Company Overview 44

5.15.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 44

5.16 University of Minnesota Company Overview 45

5.16.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 45

5.17 University of Wisconsin Madison Company Overview 46

5.17.1 University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview 46

5.18 Valor Medical Inc Company Overview 47

5.18.1 Valor Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 47

5.19 Vascular Solutions Inc Company Overview 48

5.19.1 Vascular Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview 48

6 Embolization and Coiling Devices- Recent Developments 49

6.1 May 09, 2017: Penumbra Reports First Quarter 2017 Financial Results 49

6.2 Apr 27, 2017: Boston Scientific Announces Results For First Quarter 2017 49

6.3 Apr 27, 2017: Merit Medical Reports Results for First Quarter of 2017 50

6.4 Apr 25, 2017: Stryker reports first quarter 2017 results 51

6.5 Apr 21, 2017: Penumbra Appoints Bridget O'Rourke to its Board of Directors 52

6.6 Apr 19, 2017: Johnson & Johnson reports Q1 2017 results 53

6.7 Apr 18, 2017: Johnson & Johnson Reports 2017 First-Quarter Results 55

6.8 Mar 30, 2017: MPSC Announces 2016 Annual Results 57

6.9 Mar 07, 2017: MicroVention And Terumo Announce Data From Multicenter GREAT Study 58

6.10 Feb 28, 2017: Penumbra Reports Fourth Quarter and Full Year 2016 Financial Results 59

6.11 Feb 21, 2017: Neuravi Announces Completion of Patient Enrollment in Clinical Trial of a Novel Stent Retriever for Acute Ischemic Stroke 60

6.12 Feb 21, 2017: Medtronic Reports Third Quarter Financial Results 61

6.13 Feb 21, 2017: Merit Medical Reports Results for Fourth Quarter and Year Ended December 31, 2016 64

6.14 Feb 09, 2017: Terumo Announces Change of Executive Officers 65

6.15 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors 66

6.16 Feb 02, 2017: Boston Scientific Announces Results For Fourth Quarter And Full Year Ended December 31, 2016 67

6.17 Jan 31, 2017: Terumo Opens a Branch in Yangon 68

6.18 Jan 24, 2017: Stryker reports 2016 results and 2017 outlook 68

6.19 Jan 24, 2017: Johnson & Johnson Reports 2016 Fourth-Quarter Results 70

6.20 Jan 10, 2017: Stryker provides 2016 preliminary net sales results 72

6.21 Jan 09, 2017: Johnson & Johnson Medical Devices Companies Launch CareAdvantage, a Suite of Holistic, Insights-Driven Capabilities to Help U.S. Health Systems Navigate Value-Based Care 74

6.22 Dec 19, 2016: Penumbra Appoints Thomas C. Wilder to its Board of Directors 75

6.23 Dec 12, 2016: Terumo Formulates 5-Year Mid- to Long-term Growth Strategy 75

6.24 Nov 22, 2016: Medtronic Reports Second Quarter Financial Results 76

6.25 Nov 22, 2016: Collagen Matrix Names Oystein Valberg as Chief Financial Officer 79

6.26 Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report 79

6.27 Nov 15, 2016: Penumbra Announces Resignation of Board Member 80

6.28 Nov 15, 2016: CEVA to work with Medtronic for distribution facility construction 80

6.29 Nov 03, 2016: Penumbra Reports Third Quarter 2016 Financial Results 81

6.30 Oct 27, 2016: Stryker reports third quarter 2016 results 81

6.31 Oct 26, 2016: Boston Scientific Announces Results For Third Quarter 2016 83

6.32 Oct 26, 2016: Merit Medical Reports Sales Up

15.3% for the Quarter Ended September 30, 2016 84

6.33 Oct 24, 2016: Vascular Solutions Reports Third Quarter Results 85

6.34 Oct 18, 2016: Johnson & Johnson Reports 2016 Third-Quarter Results 88

6.35 Oct 14, 2016: Medtronic Announces Voluntary Recall of Its Pipeline Embolization Device, Alligator Retrieval Device, X-Celerator Hydrophilic Guidewire, Ultraflow and Marathon Flow Directed Micro Catheters 89

6.36 Oct 10, 2016: Professor Ian Meredith To Join Boston Scientific As Executive Vice President And Global Chief Medical Officer 90

6.37 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services 91

6.38 Sep 07, 2016: Neuravi Announces European Launch of EmboTrap II Stent Retriever for the Treatment of Acute Stroke 92

6.39 Aug 30, 2016: MPSC Announces 2016 Interim Results 93

6.40 Aug 25, 2016: Medtronic Reports First Quarter Financial Results 94

6.41 Aug 09, 2016: Penumbra Reports Second Quarter 2016 Financial Results 97

6.42 Jul 28, 2016: Boston Scientific Announces Results For Second Quarter 2016 97

6.43 Jul 27, 2016: Merit Medical Reports Sales Up

9.4% for the Quarter Ended June 30, 2016 99

6.44 Jul 26, 2016: Merit Medical Announces Appointment of New Director 100

6.45 Jul 25, 2016: Vascular Solutions Reports Second Quarter Results 100

6.46 Jul 25, 2016: Neuravi Selects Robert Colloton to Lead U.S. Commercialization of Innovative Stent Retriever 103

6.47 Jul 21, 2016: Stryker reports second quarter 2016 results 104

6.48 Jul 19, 2016: Johnson & Johnson Reports 2016 Second-Quarter Results 105

6.49 Jul 13, 2016: Boston Scientific Elects Yoshiaki Fujimori to Board of Directors 107

6.50 Jun 30, 2016: NuVasive Agrees to Settle Patent Litigation With Medtronic 107

6.51 Jun 24, 2016: Collagen Matrix Names Bill Messer as Vice President, Sales and Marketing 108

6.52 Jun 22, 2016: Johnson & Johnson Announces Retirement of Louise Mehrotra and Appointment of Joseph Wolk as Vice President of Investor Relations 108

6.53 Jun 08, 2016: Boston Scientific Announces Restructuring Program to Support Long-Term Growth and Innovation 109

6.54 Jun 06, 2016: Medtronic Outlines Future Growth Vision at Investor Day 109

6.55 May 31, 2016: Medtronic Reports Fourth Quarter and Fiscal Year 2016 Financial Results 110

7 Appendix 114

7.1 Methodology 114

7.2 About GlobalData 117

7.3 Contact Us 117

7.4 Disclaimer 117

List of Tables

Table 1: Embolization and Coiling Devices – Pipeline Products by Stage of Development 8

Table 2: Embolization and Coiling Devices – Pipeline Products by Segment 9

Table 3: Embolization and Coiling Devices – Pipeline Products by Territory 10

Table 4: Embolization and Coiling Devices – Pipeline Products by Regulatory Path 11

Table 5: Embolization and Coiling Devices – Pipeline Products by Estimated Approval Date 12

Table 6: Embolization and Coiling Devices – Ongoing Clinical Trials 13

Table 7: Embolization and Coiling Devices Companies – Pipeline Products by Stage of Development 14

Table 8: Embolization and Coiling Devices – Pipeline Products by Stage of Development 15

Table 9: Aneuclose LLC Pipeline Products & Ongoing Clinical Trials Overview 16

Table 12: Avantec Vascular Corporation Pipeline Products & Ongoing Clinical Trials Overview 17

Table 15: BioCure, Inc. Pipeline Products & Ongoing Clinical Trials Overview 18

Table 18: Collagen Matrix Inc Pipeline Products & Ongoing Clinical Trials Overview 19

Table 21: DePuy Synthes Inc Pipeline Products & Ongoing Clinical Trials Overview 20

Table 24: Insera Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview 21

Table 27: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 22

Table 34: MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 26

Table 39: MicroVention, Inc. Pipeline Products & Ongoing Clinical Trials Overview 29

Table 52: MiVi Neuroscience, LLC Pipeline Products & Ongoing Clinical Trials Overview 35

Table 55: Neuravi Ltd Pipeline Products & Ongoing Clinical Trials Overview 36

Table 63: Shape Memory Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 40

Table 66: Taewoong Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 41

Table 69: Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview 43

Table 72: University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 44

Table 75: University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 45

Table 78: University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview 46

Table 81: Valor Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 47

Table 84: Vascular Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview 48

Table 87: Glossary 116

List of Figures

Figure 1: Embolization and Coiling Devices – Pipeline Products by Stage of Development 8

Figure 2: Embolization and Coiling Devices – Pipeline Products by Segment 9

Figure 3: Embolization and Coiling Devices – Pipeline Products by Territory 10

Figure 4: Embolization and Coiling Devices – Pipeline Products by Regulatory Path 11

Figure 5: Embolization and Coiling Devices – Pipeline Products by Estimated Approval Date 12

Figure 6: Embolization and Coiling Devices – Ongoing Clinical Trials 13

    Pricing

Discounts available for multiple purchases.

reportstore@globaldata.com
+44 20 7947 2745

Join our mailing list

Saved reports